Ernest G. Therkorn

Array ( [id] => 8712834 [patent_doc_number] => 08398972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Methods of treating dementia using a GM-CSF antagonist' [patent_app_type] => utility [patent_app_number] => 12/704396 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17158 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12704396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500409 [patent_doc_number] => 20110262938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Determination of the amount of hLHB core fragment in a sample from a subject and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/658098 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 28847 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262938.pdf [firstpage_image] =>[orig_patent_app_number] => 12658098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742144 [patent_doc_number] => 20120020913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'METHODS FOR PANCREATIC TISSUE REGENERATION' [patent_app_type] => utility [patent_app_number] => 13/146551 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16342 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020913.pdf [firstpage_image] =>[orig_patent_app_number] => 13146551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521663 [patent_doc_number] => 09605048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Human soluble CD146, preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/146758 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16444 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13146758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506063 [patent_doc_number] => 20100210508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Method for the Massive Culture of Cells Producing Recombinant Human Erythropoietin' [patent_app_type] => utility [patent_app_number] => 12/647849 [patent_app_country] => US [patent_app_date] => 2009-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4152 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210508.pdf [firstpage_image] =>[orig_patent_app_number] => 12647849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266456 [patent_doc_number] => 20100298229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'OSTEOPROTEGERIN' [patent_app_type] => utility [patent_app_number] => 12/637722 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 35512 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298229.pdf [firstpage_image] =>[orig_patent_app_number] => 12637722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6383280 [patent_doc_number] => 20100317046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Non-Endogenous, Constitutively Activated Versions of Human G Protein Coupled Receptor: FSHR' [patent_app_type] => utility [patent_app_number] => 12/630698 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16490 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317046.pdf [firstpage_image] =>[orig_patent_app_number] => 12630698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10057533 [patent_doc_number] => 09096879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Method of supplementing culture media to prevent undesirable amino acid substitutions' [patent_app_type] => utility [patent_app_number] => 13/511203 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26436 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9529764 [patent_doc_number] => 08753632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Antibodies to modified human IGF-1/E peptides' [patent_app_type] => utility [patent_app_number] => 13/128335 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8672 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555465 [patent_doc_number] => 08067366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Facilitation of resuscitation from cardiac arrest by erythropoietin' [patent_app_type] => utility [patent_app_number] => 12/613919 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 13240 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067366.pdf [firstpage_image] =>[orig_patent_app_number] => 12613919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4514653 [patent_doc_number] => 07910543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => 'Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors' [patent_app_type] => utility [patent_app_number] => 12/604609 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 58 [patent_no_of_words] => 22900 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910543.pdf [firstpage_image] =>[orig_patent_app_number] => 12604609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499508 [patent_doc_number] => 20110262466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'COMPOSITIONS CONTAINING THROMBOMODULIN DOMAINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/124295 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10668 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262466.pdf [firstpage_image] =>[orig_patent_app_number] => 13124295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742286 [patent_doc_number] => 20120020974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'OPTIMIZING ERYTHROPOIETIN THERAPY' [patent_app_type] => utility [patent_app_number] => 13/123841 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10977 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020974.pdf [firstpage_image] =>[orig_patent_app_number] => 13123841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601014 [patent_doc_number] => 20100098696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'FIBROBLAST GROWTH FACTOR RECEPTOR-3 (FGFR-3) INHIBITORS AND METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/579825 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13101 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098696.pdf [firstpage_image] =>[orig_patent_app_number] => 12579825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4517773 [patent_doc_number] => 07939071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Artery- and vein-specific proteins and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/567547 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 13641 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939071.pdf [firstpage_image] =>[orig_patent_app_number] => 12567547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278427 [patent_doc_number] => 20120172299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'PURIFICATION OF ERYTHROPOIETIN' [patent_app_type] => utility [patent_app_number] => 13/120646 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11396 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10063901 [patent_doc_number] => 09102732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Antibodies against glucagon receptor and their use' [patent_app_type] => utility [patent_app_number] => 13/394463 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6126 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280333 [patent_doc_number] => 20100119505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Estrogen Related Receptor, ERRalpha, A Regulator of Bone Formation' [patent_app_type] => utility [patent_app_number] => 12/538536 [patent_app_country] => US [patent_app_date] => 2009-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15794 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119505.pdf [firstpage_image] =>[orig_patent_app_number] => 12538536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377643 [patent_doc_number] => 20100081614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'LONG-ACTING GROWTH HORMONE AND METHODS OF PRODUCING SAME' [patent_app_type] => utility [patent_app_number] => 12/509188 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23064 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081614.pdf [firstpage_image] =>[orig_patent_app_number] => 12509188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174030 [patent_doc_number] => 20110177025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 13/054428 [patent_app_country] => US [patent_app_date] => 2009-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 21089 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177025.pdf [firstpage_image] =>[orig_patent_app_number] => 13054428 [rel_patent_id] =>[rel_patent_doc_number] =>)